Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis

Journal of Rheumatology

Volumn 33, Issue 10, 2006, Pages 1973-1979

  Cleland, Leslie G ^a   Caughey, Gillian E ^a   James, Michael J ^a   Proudmam, Susanna M ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Cardiovascular risk; Combination therapy; Cyclooxygenase inhibition; Early rheumatoid arthritis; Fish oil; Remission

Indexed keywords

ARACHIDONIC ACID; AUROTHIOMALATE; FISH OIL; HYDROXYCHLOROQUINE; ICOSAPENTAENOIC ACID; LEFLUNOMIDE; LIPOPOLYSACCHARIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SALAZOSULFAPYRIDINE; STEROID; THROMBOXANE A2; THROMBOXANE B2;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUSTRALIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DRUG USE; ENZYME ACTIVATION; ENZYME INHIBITION; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REMISSION; RHEUMATOID ARTHRITIS; RISK REDUCTION; SYMPTOM;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARACHIDONIC ACID; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EICOSANOIDS; FEMALE; FISH OILS; HUMANS; HYDROXYCHLOROQUINE; MALE; METHOTREXATE; MIDDLE AGED; RISK FACTORS; SULFASALAZINE; THROMBOXANE A2;

EID: 33750016798     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kremer JM, Lawrence DA, Jubiz W, et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Arthritis Rheum 1990;33:810-20.
2. Kremer JM, Lawrence DA, Petrillo GF, et al. Effects of high-close fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs. Arthritis Rheum 1995;38:1107-14.
3. Fortin PR, Lew RA, Liang MH, et al. Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. J Clin Epidemiol 1995;48:1379-90.
4. Cleland LG, James MJ, Proudman SM, Fish oil: what the prescriber needs to know. Arthritis Res Ther 2005;8:202 [Epub ahead of print].
5. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor α and interleukin-1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996;63:116-22.
6. Mantzioris E, Cleland LG, Gibson RA, et al. Biochemical effects of a diet containing foods enriched with n-3 fatty acids. Am J Clin Nutr 2000;72:42-8.
7. Lands WEM. Biosynthesis of prostaglandins. Annu Rev Nutr 1991;11:41-60.
8. Akiba S, Murata T, Kitatani K, Sato T. Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation. Biol Pharm Bull 2000;23:1293-7.
9. Skoldstam L, Borjesson O, Kjallman A, Seiving B, Akesson B. Effect of six months of fish oil supplementation in stable rheumatoid arthritis. A double blind, controlled study. Scand J Rheumatol 1992;21:178-85.
10. Lau CS, Morley KD, Belch JJF. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis - a double blind placebo controlled study. Br J Rheumatol 1993;32:982-9.
11. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. Arthritis Rheum 1994;37:824-9.
12. O'Keefe JH Jr, Harris WS. From Inuit to implementation: omega-3 fatty acids come of age. Mayo Clin Proc 2000;75:607-14.
13. Solomon DH. Selective cyclooxygenase 2 inhibitors and cardiovascular events. Arthritis Rheum 2005;52:1968-78.
14. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005;330:1366.
15. Krause D, Schleusser B, Herborn G, Rau R. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000;43:14-21.
16. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-32.
17. Cleland LG, James MJ, Proudman SM. The role of fish oils in the treatment of rheumatoid arthritis. Drugs 2003;63:845-53.
18. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
19. Harris WS, Von Schacky C, The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med 2004;39:212-20.
20. Pincus T, Brooks RH, Callahan LF. A proposed 30-45 minute 4 page standard protocol to evaluate rheumatoid arthritis (SPERA) that includes measures of inflammatory activity, joint damage, and longterm outcomes. J Rheumatol 1999;26:473-80.
21. Cleland LG, French JK, Belts WH, Murphy GA, Elliott M. Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 1988;15:1471-5.
22. Volker D, Fitzgerald P, Major G, Garg M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol 2000;27:2343-6.
23. van der Tempel H, Tulleken JE, Limburg PC, Muskiet FAJ, van Rijswijk MH. Effects of fish oil supplementation in rheumatoid arthritis. Ann Rheum Dis 1990;49:76-80.
24. De Caterina R, Giannessi D, Mazzone A, et al. Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery. Circulation 1990;82:428-38.
25. Boku K, Ohno T, Saeki T, et al. Adaptive cytoprotection mediated by prostaglandin 1(2) is attributable to sensitization of CRGP-containing sensory nerves. Gastroenterology 2001;120:134-43.
26. Takenchi K, Kato S, Takeeda M, et al. Facilitation by endogenous prostaglandins of capsaicin-induced gastric protection in rodents through EP2 and 1P receptors. J Pharmacol Exp Ther 2003;304:1055-62.
27. Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-6.
28. Endres S, Whitaker RE, Ghorbani R, Meydani SN, Dinarello CA. Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 beta and of tumour necrosis factor-alpha ex vivo. Immunology 1996;87:264-70.
29. Demasi M, Cleland LG, Cook-Johnson RJ, Caughey GE, James MJ. Effects of hypoxia on monocyte inflammatory mediator production: dissociation between changes in cyclooxygcnase-2 expression and eicosanoid synthesis. J Biol Chem 2003;278:38607-16.
30. Caughey GE, Pouliot M, Cleland LG, James MJ. Regulation of tumor necrosis factor alpha and interleukin-1 beta synthesis by thromboxane A, in non-adherent human monocytes. J Immunol 1997;158:351-8.
31. Zhao Y, Joshi-Barve S, Barve S, Chen LH. Eicosapentaenoic acid prevents LPS-induced TNF-alpha expression by preventing NF-kappa B activation. J Am Coll Nutr 2004;23:71-8.
32. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402-11.
33. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002;20:1493-9.
34. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002;106:2747-57.
35. GISSI Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55.
36. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of cardiac arrest. JAMA 1995;274:1363-7.
37. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346:1113-8.
38. Bathon JM, Genovese MC. The Early Rheumatoid Arthritis (ERA) trial comparing the efficacy and safety of etanercept and methotrexate. Clin Exp Rheumatol 2003;21:5195-7.